4EBP1/c-MYC/PUMA and NF-κB/EGR1/BIM pathways underlie cytotoxicity of mTOR dual inhibitors in malignant lymphoid cells.
暂无分享，去创建一个
K. Flatten | B. Smith | J. Karp | S. Kaufmann | K. Pratz | Haiming Dai | P. Schneider | L. Almada | K. Knorr | Luciana L Almada | A. Hess | A. W. Hendrickson | Seongseok Yun | Nicole D. Vincelette | Kevin L. Peterson | M. Fernandez-Zapico | Nicole D Vincelette | Kevin L. Peterson | Katherine Knorr | B. D. Smith | Paula A. Schneider | ScottH Kaufmann | Allan D. Hess | Andrea E. Wahner Hendrickson